Efficacy of Methimazole Dosing Algorithm
Megadott ok: Unable to reach recruiting goals
A legfontosabb adatok
- Hol
- Chicago (Egyesült Államok)A helyszín megnézése
Helyszínek itt: Egyesült Államok
- Cook County HealthChicago, Egyesült ÁllamokNo longer taking part
A vizsgálat adatai
- Ki végzi
- Cook County Health
- Azonosító
- NCT05964452
- A regiszteradat frissítve
- 2024. december 27.
- Eredeti leírás
To prospectively study the efficacy and safety of the Cook County Health (CCH) methimazole (MMI) dosing algorithm in the setting of new onset Graves' disease.A teljes eredeti leírásKevesebb
The Efficacy of Cook County Health's Methimazole Dosing Algorithm in the Setting of Ne Onset Graves' Hyperthyroidism
To prospectively study the efficacy and safety of the Cook County Health (CCH) methimazole (MMI) dosing algorithm in the setting of new onset Graves' disease.
Bevonási feltételek: Non-pregnant adults (>18 years of age) with new diagnosis of Graves' Disease (elevated free T4, Free T3, low or suppressed TSH, positive TSI and or thyroid eye disease) and; either drug naïve or who have been initiated on MMI within previous 4-6 weeks per CCH algorithm.
Kizáró feltételek: Pregnant patients; hyperthyroidism due to other causes, example - Toxic Multinodular Goiter, Iodine induced thyrotoxicosis, etc; Graves patients who present with atrial fibrillation, CHF or other end organ damage.